Results 241 to 250 of about 587,070 (347)

Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Sarcopenia, an important complication of chronic obstructive pulmonary disease (COPD), is significantly associated with increased mortality. Systemic inflammation is an important trigger of COPD‐related skeletal muscle dysfunction. Calprotectin is a damage‐associated molecular pattern involved in the inflammatory response, but its ...
Liwei Liao, Jiaye Li, Weidong Xu, Yan Yin, Zilin Wang, Chang Li, Yanxia Li, Xiaoming Zhou, Mingming Deng, Gang Hou   +9 more
wiley   +1 more source

Are Image-Based Deep Learning Algorithms of Kidney Volume in Polycystic Kidney Disease Ready for Clinical Deployment? A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Colliander E, Tupper S, Kielberg ML, Liu ML, Almar-Munoz E, Mayr A, Mirón Mombiela R.   +6 more
europepmc   +1 more source

Acquired cystic kidney disease

, 2014
Fahad Alabdulghani, Arlene Campos, Mostafa Elfeky   +2 more
openaire   +1 more source

Circulating Metabolites Treat Human TMJ‐OA by Eliminating Senescent Chondrocytes via the C1QBP/C1q/p14ARF Axis

Journal of Extracellular Vesicles, Volume 15, Issue 2, February 2026.
ABSTRACT Temporomandibular joint osteoarthritis (TMJ‐OA) is a progressive degenerative disorder, for which therapeutic interventions remain limited. The disruption of metabolic homeostasis plays a critical role in the pathogenesis and advancement of TMJ‐OA.
Bowen Meng, Xin Li, Benyi Yang, Yan Qu, Yifan He, Chaoran Fu, Zhe An, Antong Wu, Yuzhuo Hei, Rong Zhang, Wenyi Cai, Lingyunbo Kong, Rui Li, Meng Hao, Zeyuan Cao, Xueli Mao, Janak Lal Pathak, Yang Cao, Songtao Shi, Qingbin Zhang   +19 more
wiley   +1 more source

Anticodon-edited tRNA enables translational readthrough of COL4A5 premature termination codons. [PDF]

PLoS One
Omachi K, Porter JJ, Lueck JD, Miner JH.
europepmc   +1 more source

Nanomedicine Strategies Against Biofilm‐Associated Infections: Advances, Challenges, and Translational Barriers

MicrobiologyOpen, Volume 15, Issue 1, February 2026.
Explore the key challenges and limitations in nanomedicine for biofilm treatment, from drug loading efficiency to antimicrobial resistance. ABSTRACT Antimicrobial resistance continues to rise globally, with biofilm‐associated infections intensifying the clinical burden through persistent tolerance to antibiotics and evasion of immune responses ...
Husni Farah, Munthar Kadhim‐Abosaoda, Hayjaa Mohaisen‐Mousa, S. Renuka Jyothi, Priya Priyadarshini‐Nayak, J. Bethanney Janney, Gurjant Singh, Ashish Singh‐Chauhan, Manoj Kumar‐Mishra   +8 more
wiley   +1 more source

Genetic diagnosis and prenatal diagnosis of patients with cystic kidney disease in Southwest China. [PDF]

BMC Nephrol
Zhou C, Xiao Y, Xie H, Wei X, Wang J.
europepmc   +1 more source

Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Comparative analysis of multiple cell culture models. The 3D microfluidic organ‐on‐a‐chip, which is superior to the existing models in multiple aspects, can be more conducive to new studies and discoveries related to human beings. Created with BioRender (www.biorender.com).
Xuxia Cao, Congmin Xia, Caifeng Li, Shiwen Deng, Junxian Cao, Hongjun Yang, Shaoping Wang, Peng Chen   +7 more
wiley   +1 more source

Synchronous angiomyolipoma with epithelial cysts and clear cell renal cell carcinoma: a case report. [PDF]

Front Oncol
Wang J, Ren C, Qiang Z, Li J, Ren H, Chen G, Gong X, Zhang J.   +7 more
europepmc   +1 more source

Progress in RNA‐Targeted Therapeutics for Human Diseases

MedComm, Volume 7, Issue 2, February 2026.
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang, Aimin Jiang, Bin‐Kui Jia, Yuming Jin, Yinghu Chen, Zhaoyu Li, Yan Liao, Haoling Zhang, Zhiheng Lin, Xiao Fang, Linhui Wang   +10 more
wiley   +1 more source